Product
TST005
1 clinical trial
1 drug
2 indications
Indication
Locally Advanced or Metastatic CancersDrug
TST005Clinical trial
A Phase 1, First in Human, Open-label, Dose Escalation and Dose Expansion Study of TST005 in Patients With Locally Advanced or Metastatic Solid TumorsStatus: Terminated, Estimated PCD: 2023-09-30